Evidence map›Paper›PMID 41980835›Full record

ReviewCanadian family physician Medecin de famille canadien2026

Approach to osteoporosis diagnosis and fracture risk management in primary care.

Divya Garg, Julia MacLaren, Candice Stapleton, Vishal Bhella, Janine Payne, Emma Billington

Abstract readReview
In one paragraph

Review in Canadian family physician Medecin de famille canadien, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Divya GargClinical Associate Professor in the Department of Family Medicine in the Cumming School of Medicine at the University of Calgary in Alberta.
Julia MacLarenRegistered dietitian and Graduate Researcher in the Cumming School of Medicine at the University of Calgary.
Candice StapletonPhysiotherapist and Exercise Consultant in the Alberta Healthy Living Program at Primary Care Alberta.
Vishal BhellaClinical Associate Professor in the Department of Family Medicine in the Cumming School of Medicine at the University of Calgary.
Janine PayneRegistered dietitian in the Alberta Healthy Living Program at Primary Care Alberta.
Emma BillingtonClinical Assistant Professor in the Division of Endocrinology and Metabolism in the Cumming School of Medicine at the University of Calgary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo outline strategies to reduce osteoporosis-related fracture risk through pharmacologic and nonpharmacologic interventions; to examine the role of the Fracture Risk Assessment Tool (FRAX) and bone mineral density (BMD) testing in fracture risk evaluation and periodic monitoring; and to outline evidence-informed interventions for optimizing nutrition, exercise, and pharmacotherapy. SOURCES OF INFORMATION: Recent Canadian guidelines from Osteoporosis Canada, the Canadian Task Force on Preventive Health Care, and the Society of Obstetricians and Gynaecologists of Canada. MAIN MESSAGE: Both BMD testing and FRAX are endorsed by Canadian guidelines for fracture risk assessment. Guidelines support clinical evaluation of fracture risk, particularly in females 65 years or older, with variations in age- and sex-specific screening recommendations between 50 and 64 years. Effective bone health management integrates pharmacologic and nonpharmacologic strategies to prevent falls and fractures.

conclusionGuidelines recommend prioritizing fracture risk screening in females 65 years or older with risk factor assessment and FRAX application. Evaluation should include assessment of fall risk and signs of undiagnosed vertebral fractures. Risk assessment and shared decision making should guide further evaluation with BMD testing. Osteoporosis Canada suggests targeting screening as per fracture risk in postmenopausal females 65 years or younger and males 50 years or older, noting limited supporting evidence. Adults 50 years or older should engage in balance, functional, and resistance training twice weekly, and follow Health Canada's recommendations for calcium and vitamin D intake, including a vitamin D supplement of 400 IU daily. Pharmacologic therapy is recommended for those with prior hip or vertebral fracture, 2 or more osteoporotic fractures, a 10-year fracture risk 20% or higher, or a T-score -2.5 or less and age 70 years or older, guided by patient values and preference.

Indexed as

OsteoporosisOsteoporotic FracturesAgedBone DensityBone Density Conservation AgentsCanadaFemaleHumansMaleMass ScreeningMiddle AgedPractice Guidelines as TopicPrimary Health CareRisk AssessmentRisk FactorsRisk ManagementBone Density Conservation Agents

Identifiers

PMID41980835
PMCPMC13078823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.